The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis

Atherosclerosis

Volumn 168, Issue 1, 2003, Pages 147-152

  Kakko, Sakari ^a   Päivänsalo, Markku ^a   Koistinen, Pirjo ^a   Kesäniemi, Y Antero ^a   Kinnula, Vuokko L ^a   Savolainen, Markku J ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Anti oxidant enzyme; Atherosclerosis; Genetic polymorphisms; Intima media thickness; Quantitative trait locus; Redox state

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANGANESE SUPEROXIDE DISMUTASE; SIGNAL PEPTIDE;

ADULT; ALLELE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HUMAN; HYPERTENSION; INTIMA; MAJOR CLINICAL STUDY; MALE; MNSOD GENE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN INTERACTION; ULTRASOUND;

EID: 0037727872     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00091-1     Document Type: Article

References (38)

1. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
2. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241.
3. Kunsch C., Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 85:1999;753-766.
4. Marui N., Offermann M.K., Swerlick R., et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1993;1866-1874.
5. Weber C., Erl W., Pietsch A., Strobel M., Ziegler-Heitbrock H.W., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor- kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. 14:1994;1665-1673.
6. Satriano J.A., Shuldiner M., Hora K., Xing Y., Shan Z., Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J. Clin. Invest. 92:1993;1564-1571.
7. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
8. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
9. Marklund S.L. Human copper-containing superoxide dismutase of high molecular weight. Proc. Natl. Acad. Sci. USA. 79:1982;7634-7638.
10. Oury T.D., Day B.J., Crapo J.D. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radical. Biol. Med. 20:1996;957-965.
11. Ukkola O., Erkkilä P.H., Savolainen M.J., Kesäniemi Y.A. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J. Int. Med. 249:2001;451-459.
12. Li Y., Huang T.T., Carlson E.J., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11:1995;376-381.
13. Lebovitz R.M., Zhang H., Vogel H., et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA. 93:1996;9782-9787.
14. Ohlemiller K.K., McFadden S.L., Ding D.L., et al. Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (Sod1) increases susceptibility to noise-induced hearing loss. Audiol. Neuro-otol. 4:1999;237-246.
15. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem. Biophys. Res. Commun. 226:1996;561-565.
16. Rosenblum J.S., Gilula N.B., Lerner R.A. On signal sequence polymorphisms and diseases of distribution. Proc. Natl. Acad. Sci. USA. 93:1996;4471-4473.
17. Allayee H., Aouizerat B.E., Cantor R.M., et al. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. Am. J. Hum. Genet. 63:1998;577-585.
18. Austin M.A., Stephens K., Walden C.E., Wijsman E. Linkage analysis of candidate genes and the small, dense low-density lipoprotein phenotype. Atherosclerosis. 142:1999;79-87.
19. Chen Z., Siu B., Ho Y.S., Vincent R., Chua C.C., Hamdy R.C., et al. Overexpression of MnSOD protects against myocardial ischemia/reperfusion repercussion injury in transgenic mice. J. Mol. Cell. Cardiol. 30:1998;2281-2289.
20. Zanetti M., Sato J., Jost C.J., Gloviczki P., Katusic Z.S., O'Brien T. Gene transfer of manganese superoxide dismutase reverses vascular dysfunction in the absence but not in the presence of atherosclerotic plaque. Hum. Gene Ther. 12:2001;1407-1416.
21. Fang X., Weintraub N.L., Rios C.D., et al. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ. Res. 82:1998;1289-1297.
22. Kinscherf R., Deigner H.P., Usinger C., et al. Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemia rabbits. FASEB J. 11:1997;1317-1328.
23. Ballinger S.W., Patterson C., Knight-Lozano C.A., et al. Mitochondrial integrity and function in atherogenesis. Circulation. 106:2002;544-549.
24. Hiroi S., Harada H., Nishi H., Satoh M., Nagai R., Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem. Biophys. Res. Commun. 261:1999;332-339.
25. Wendelhag I., Gustavsson T., Suurkula M., Berglund G., Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin. Physiol. 11:1991;565-577.
26. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340:1999;14-22.
27. Rantala A.O., Kauma H., Lilja M., Savolainen M.J., Reunanen A., Kesäniemi Y.A. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245:1999;163-174.
28. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic. Acids Res. 16:1988;1215.
29. Kauma H., Päivänsalo M., Savolainen M.J., et al. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J. Hypertens. 14:1996;1183-1187.
30. Gerdes V.E., ten Cate H., de Groot E., et al. Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis. Atherosclerosis. 163:2002;135-140.
31. Djousse L., Myers R.H., Province M.A., et al. Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke. 33:2002;1357-1361.
32. Kakko S., Tamminen M., Päivänsalo M., et al. Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur. J. Clin. Invest. 31:2001;593-602.
33. Kawamoto R., Kohara K., Tabara Y., Miki T., Doi T., Tokunaga H., et al. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis. J. Hum. Genet. 46:2001;506-510.
34. Malin R., Loimaala A., Nenonen A., et al. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men. Metabolism. 50:2001;1095-1101.
35. Lembo G., De Luca N., Battagli C., et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke. 32:2001;735-740.
36. Duggirala R., Gonzalez V.C., O'Leary D.H., Stern M.P., Blangero J. Genetic basis of variation in carotid artery wall thickness. Stroke. 27:1996;833-837.
37. Xiang A.H., Azen S.P., Buchanan T.A., et al. Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent. Arterioscler. Thromb. Vas. Biol. 22:2002;843-848.
38. Lange L.A., Bowden D.W., Langefeld C.D. Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke. 33:2002;1876-1881.